Effect of vitamin D supplementation versus placebo on hypertension in patients with vitamin D deficiency
Phase 2
Recruiting
- Conditions
- Vitamin D deficiency.Vitamin D deficiency
- Registration Number
- IRCT201703129014N151
- Lead Sponsor
- Vice-chancellor for Research the Technology, Hamadan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 208
Inclusion Criteria
Age of 18 to 75 years; systolic blood pressure equal to or greater than 140 mmHg or diastolic blood pressure equal to or greater than 90 mmHg in tow times; vitamin D deficiency.
Exclusion criteria: Pregnancy; secondary hypertension; renal failure; a history of using vitamin D or calcium during the last three months; using Thiazide-type diuretics.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Measuring systolic and diastolic blood pressure. Timepoint: before intervention and then monthly for 2 months. Method of measurement: in sitting position from the right hand using mercury sphygmomanometer.
- Secondary Outcome Measures
Name Time Method Measuring serum Calciferol. Timepoint: before intervention and then monthly for 2 months. Method of measurement: through laboratory test.